myelodysplastic syndromes (MDS)

Catherine Lai, MD, MPH, is the director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center. Board certified in hematology, medical oncology, and internal medicine, Dr. Lai specializes in detecting, monitoring, and treating acute leukemia in adults. Previously at the National Institutes of Health (NIH), she focused on clinical trials in acute leukemias. Under Dr. Lai’s leadership, the leukemia program offers acute leukemia patients advanced and highly specialized care, including clinical trials with immunotherapy. Dr.

Dr. Nimer has been conducting extensive clinical and basic science research into the treatment, and genetic basis of adult leukemia and

Dr. Pamela Becker is available for consultation with patients, family members and caregivers via email at pbecker@uw.edu

Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania. She joined Dana-Farber as a member of the Adult Leukemia program in 2016.